Free Trial

Canvas Wealth Advisors LLC Purchases 182,234 Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

DENTSPLY SIRONA logo with Medical background

Canvas Wealth Advisors LLC grew its holdings in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 126.5% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 326,298 shares of the medical instruments supplier's stock after purchasing an additional 182,234 shares during the period. DENTSPLY SIRONA makes up 1.6% of Canvas Wealth Advisors LLC's portfolio, making the stock its 21st biggest holding. Canvas Wealth Advisors LLC owned 0.16% of DENTSPLY SIRONA worth $6,245,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also made changes to their positions in the business. UMB Bank n.a. raised its holdings in shares of DENTSPLY SIRONA by 430.3% during the third quarter. UMB Bank n.a. now owns 928 shares of the medical instruments supplier's stock valued at $25,000 after acquiring an additional 753 shares during the period. Capital Performance Advisors LLP purchased a new position in DENTSPLY SIRONA during the 3rd quarter worth approximately $27,000. MassMutual Private Wealth & Trust FSB raised its stake in DENTSPLY SIRONA by 648.4% during the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 1,422 shares of the medical instruments supplier's stock valued at $27,000 after purchasing an additional 1,232 shares during the period. Kennebec Savings Bank purchased a new stake in shares of DENTSPLY SIRONA in the third quarter valued at $35,000. Finally, Van ECK Associates Corp acquired a new stake in shares of DENTSPLY SIRONA in the third quarter worth $42,000. 95.70% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

XRAY has been the subject of several research analyst reports. Mizuho initiated coverage on DENTSPLY SIRONA in a research note on Wednesday, December 4th. They issued a "neutral" rating and a $21.00 price objective for the company. Evercore ISI restated an "in-line" rating and set a $20.00 price target on shares of DENTSPLY SIRONA in a report on Tuesday, January 7th. Morgan Stanley dropped their price objective on shares of DENTSPLY SIRONA from $30.00 to $23.00 and set an "overweight" rating on the stock in a research note on Tuesday, December 17th. Needham & Company LLC restated a "buy" rating and set a $25.00 price target on shares of DENTSPLY SIRONA in a report on Tuesday. Finally, Robert W. Baird cut their price objective on DENTSPLY SIRONA from $31.00 to $24.00 and set a "neutral" rating for the company in a report on Friday, November 8th. Nine research analysts have rated the stock with a hold rating and five have given a buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of "Hold" and a consensus price target of $26.33.

Read Our Latest Stock Report on XRAY

DENTSPLY SIRONA Stock Performance

Shares of NASDAQ:XRAY traded up $0.40 during trading on Thursday, hitting $18.77. 2,129,084 shares of the stock were exchanged, compared to its average volume of 2,337,103. The company has a market capitalization of $3.73 billion, a price-to-earnings ratio of -9.07, a price-to-earnings-growth ratio of 1.83 and a beta of 0.96. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.84 and a current ratio of 1.25. DENTSPLY SIRONA Inc. has a 1-year low of $17.21 and a 1-year high of $34.91. The company's fifty day simple moving average is $19.04 and its 200-day simple moving average is $22.04.

DENTSPLY SIRONA Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, January 10th. Shareholders of record on Friday, December 27th were issued a $0.16 dividend. This represents a $0.64 annualized dividend and a yield of 3.41%. The ex-dividend date was Friday, December 27th. DENTSPLY SIRONA's dividend payout ratio (DPR) is presently -30.92%.

About DENTSPLY SIRONA

(Free Report)

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.

See Also

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Should You Invest $1,000 in DENTSPLY SIRONA Right Now?

Before you consider DENTSPLY SIRONA, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DENTSPLY SIRONA wasn't on the list.

While DENTSPLY SIRONA currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings: Will it Spark a Rally or Trigger a Sell-Off?
Marjorie Taylor Greene Bought THOUSANDS in Tesla Stock
The EXACT Date of Next Stock Market Crash

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines